Ciprofloxacin

Researchers are comparing two anesthesia drugs, Ciprofol and Propofol, in children aged 3 to 11 years undergoing adenotonsillectomy or adenoidectomy. The study evaluates how these drugs perform under two types of monitoring called IoC1 and IoC2, aiming to provide evidence about Ciprofol's safety and effectiveness in pediatric anesthesia. Children in this trial are randomly assigned to one of two groups. One group receives Ciprofol during anesthesia induction and maintenance at specified doses, while the other group receives Propofol with its own dosing schedule. Throughout surgery, vital signs and monitoring parameters IoC1 and IoC2 are continuously observed. Participants will be assessed during and after anesthesia using various measures including an Induction Compliance Checklist, time to loss of consciousness, sedation and pain-stress levels, heart rate, blood pressure, anesthetic dosage, recovery time, anesthetist satisfaction, and monitoring for adverse events. Follow-up includes observations up to 24 hours post-procedure to understand recovery and possible side effects.

This research aims to evaluate whether ciprofol, a new intravenous anesthetic, can improve blood pressure stability during surgery in elderly patients who have been using renin-angiotensin system inhibitors long-term. These patients often face increased risk of low blood pressure during surgery, which can lead to serious complications like heart and kidney injury or higher mortality. Ciprofol has shown promise in previous studies for better maintaining blood pressure compared to propofol, but more evidence is needed. The study randomly assigns patients undergoing elective abdominal surgery lasting over two hours to receive either ciprofol or propofol for anesthesia induction and maintenance. Both drugs are given intravenously during surgery. The trial is designed as a triple-blind, randomized controlled trial to compare how each anesthetic affects perioperative blood pressure and related outcomes. Participants will be monitored from the start to the end of surgery for blood pressure levels, use of blood pressure medications, anesthesia success, and any adverse events. Additional measures include heart and brain oxygen levels and recovery times. Postoperative complications will be tracked for up to three months. This thorough monitoring aims to understand the safety and hemodynamic effects of ciprofol in this vulnerable group.